Cargando…
Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics
Bacterial opportunistic human pathogens frequently exhibit intrinsic antibiotic tolerance and resistance, resulting in infections that can be nearly impossible to eradicate. We asked whether this recalcitrance could be driven by these organisms’ evolutionary history as environmental microbes that en...
Autores principales: | Meirelles, Lucas A., Perry, Elena K., Bergkessel, Megan, Newman, Dianne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946323/ https://www.ncbi.nlm.nih.gov/pubmed/33690640 http://dx.doi.org/10.1371/journal.pbio.3001093 |
Ejemplares similares
-
Small-Molecule
Antibiotic Drug Development: Need and
Challenges
por: Bergkessel, Megan, et al.
Publicado: (2023) -
Erratum for Basta et al., “Identification of Fitness Determinants during Energy-Limited Growth Arrest in Pseudomonas aeruginosa”
por: Basta, David W., et al.
Publicado: (2018) -
Identification of Fitness Determinants during Energy-Limited Growth Arrest in Pseudomonas aeruginosa
por: Basta, David W., et al.
Publicado: (2017) -
Patterns of cross‐resistance and collateral sensitivity between clinical antibiotics and natural antimicrobials
por: Colclough, Abigail, et al.
Publicado: (2019) -
Collateral effects of antibiotics on mammalian gut microbiomes
por: Looft, Torey, et al.
Publicado: (2012)